Cigna Group (CI)
Cigna Group on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as hospital & medical service plans.
6.8M
Short interest
settlement 2026-10-15
4.5
Days to cover
+0.6 days vs prior
40.5%
Short share of volume
2026-10-28
5,850
Fails to deliver
settlement 2026-09-25
Thu 29 Oct
Next earnings
estimated date
-$6.3M
Insider flow, 90 days
0 buys, 3 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in CI is 6,757,391 shares, up 194,393 shares over the last month. Over the last 48 readings it ranged from 2,453,026 shares (31 July 2025) to 7,333,399 shares (15 June 2026). At the reported average volume of 1.5M shares a day that is 4.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/ci" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 6,757,391 | -2.8% | 1,506,945 | 4.48 |
| 2026-09-30 | 6,951,241 | +5.9% | 1,782,900 | 3.90 |
| 2026-09-15 | 6,562,998 | +4.6% | 1,426,427 | 4.60 |
| 2026-08-31 | 6,274,787 | +19.8% | 1,380,462 | 4.55 |
| 2026-08-14 | 5,240,030 | +9.9% | 2,152,387 | 2.43 |
| 2026-07-31 | 4,766,977 | -22.8% | 1,865,973 | 2.55 |
| 2026-07-15 | 6,178,422 | -0.8% | 1,432,328 | 4.31 |
| 2026-06-30 | 6,226,238 | -15.1% | 1,754,808 | 3.55 |
| 2026-06-15 | 7,333,399 | +21.2% | 1,481,303 | 4.95 |
| 2026-05-29 | 6,052,749 | -1.2% | 1,577,447 | 3.84 |
| 2026-05-15 | 6,127,054 | -3.4% | 1,836,163 | 3.34 |
| 2026-04-30 | 6,343,066 | -1.2% | 1,714,975 | 3.70 |
| 2026-04-15 | 6,417,492 | -5.7% | 1,150,564 | 5.58 |
| 2026-03-31 | 6,801,672 | +6.2% | 1,937,464 | 3.51 |
| 2026-03-13 | 6,404,989 | +23.1% | 1,827,757 | 3.50 |
| 2026-02-27 | 5,204,972 | +15.7% | 1,544,017 | 3.37 |
| 2026-02-13 | 4,498,128 | -2.4% | 2,266,376 | 1.98 |
| 2026-01-30 | 4,610,825 | -3.1% | 1,532,029 | 3.01 |
| 2026-01-15 | 4,757,244 | +1.4% | 1,547,144 | 3.07 |
| 2025-12-31 | 4,691,680 | +4.6% | 1,446,219 | 3.24 |
| 2025-12-15 | 4,484,017 | +14.0% | 1,702,200 | 2.63 |
| 2025-11-28 | 3,934,383 | -0.0% | 1,765,289 | 2.23 |
| 2025-11-14 | 3,934,852 | +7.2% | 3,121,635 | 1.26 |
| 2025-10-31 | 3,671,958 | -2.8% | 2,353,292 | 1.56 |
| 2025-10-15 | 3,776,937 | +6.0% | 1,387,165 | 2.72 |
| 2025-09-30 | 3,562,269 | +9.2% | 1,523,481 | 2.34 |
| 2025-09-15 | 3,261,016 | +7.3% | 1,327,865 | 2.46 |
| 2025-08-29 | 3,040,006 | -8.3% | 1,523,030 | 2.00 |
| 2025-08-15 | 3,316,471 | +35.2% | 2,203,943 | 1.50 |
| 2025-07-31 | 2,453,026 | -14.9% | 2,008,940 | 1.22 |
| 2025-07-15 | 2,882,831 | -1.4% | 1,508,941 | 1.91 |
| 2025-06-30 | 2,923,086 | -1.0% | 2,095,668 | 1.39 |
| 2025-06-13 | 2,953,657 | +8.0% | 1,798,367 | 1.64 |
| 2025-05-30 | 2,734,528 | -14.0% | 1,619,010 | 1.69 |
| 2025-05-15 | 3,181,107 | -9.6% | 2,103,549 | 1.51 |
| 2025-04-30 | 3,516,987 | +3.9% | 1,612,686 | 2.18 |
| 2025-04-15 | 3,383,773 | -1.3% | 2,102,090 | 1.61 |
| 2025-03-31 | 3,428,418 | -7.7% | 1,530,589 | 2.24 |
| 2025-03-14 | 3,714,300 | -3.8% | 1,806,952 | 2.06 |
| 2025-02-28 | 3,859,901 | +5.2% | 2,023,295 | 1.91 |
| 2025-02-14 | 3,669,290 | -10.8% | 1,696,952 | 2.16 |
| 2025-01-31 | 4,115,125 | -1.1% | 2,214,991 | 1.86 |
| 2025-01-15 | 4,160,155 | -14.0% | 1,453,245 | 2.86 |
| 2024-12-31 | 4,835,532 | +4.9% | 2,535,389 | 1.91 |
| 2024-12-13 | 4,607,862 | +44.7% | 2,417,178 | 1.91 |
| 2024-11-29 | 3,185,262 | -11.0% | 1,554,983 | 2.05 |
| 2024-11-15 | 3,580,164 | +3.6% | 2,023,543 | 1.77 |
| 2024-10-31 | 3,454,218 | +21.5% | 2,248,588 | 1.54 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of CI volume is 40.5%, down 9.7 points over the last five sessions. Over the last 30 readings it ranged from 33.8% (24 September 2026) to 67.8% (13 October 2026). The latest reading is 8.5 points below the 30-session average of 48.9%, on 397K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 161K | 397K | 40.5% | 6 |
| 2026-10-27 | 177K | 439K | 40.3% | 43 |
| 2026-10-26 | 227K | 513K | 44.1% | 68 |
| 2026-10-23 | 565K | 859K | 65.8% | 0 |
| 2026-10-22 | 333K | 596K | 55.9% | 51 |
| 2026-10-21 | 232K | 464K | 50.1% | 1,524 |
| 2026-10-20 | 215K | 452K | 47.5% | 64 |
| 2026-10-19 | 206K | 440K | 46.9% | 44 |
| 2026-10-16 | 348K | 604K | 57.6% | 15 |
| 2026-10-15 | 275K | 752K | 36.5% | 992 |
| 2026-10-14 | 191K | 474K | 40.4% | 0 |
| 2026-10-13 | 318K | 469K | 67.8% | 150 |
| 2026-10-12 | 250K | 405K | 61.8% | 0 |
| 2026-10-09 | 191K | 350K | 54.5% | 0 |
| 2026-10-08 | 239K | 563K | 42.4% | 0 |
| 2026-10-07 | 213K | 506K | 42.0% | 0 |
| 2026-10-06 | 144K | 420K | 34.3% | 14 |
| 2026-10-05 | 266K | 559K | 47.5% | 420 |
| 2026-10-02 | 342K | 730K | 46.8% | 0 |
| 2026-10-01 | 448K | 849K | 52.8% | 0 |
| 2026-09-30 | 774K | 1.2M | 62.3% | 26 |
| 2026-09-29 | 319K | 667K | 47.8% | 0 |
| 2026-09-28 | 218K | 447K | 48.9% | 0 |
| 2026-09-25 | 215K | 588K | 36.5% | 0 |
| 2026-09-24 | 260K | 770K | 33.8% | 0 |
| 2026-09-23 | 316K | 652K | 48.4% | 0 |
| 2026-09-22 | 193K | 469K | 41.3% | 6 |
| 2026-09-21 | 207K | 383K | 54.1% | 3 |
| 2026-09-18 | 206K | 389K | 52.9% | 114 |
| 2026-09-17 | 261K | 397K | 65.7% | 91 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 25 September 2026, the fails-to-deliver balance in CI is 5,850 shares, up 5,734 shares over the last settlement date. Over the last 30 readings it ranged from 4 shares (6 April 2026) to 156,016 shares (22 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-25 | 5,850 | $265.50 | $1.6M |
| 2026-09-08 | 116 | $282.52 | $33K |
| 2026-08-24 | 26 | $277.51 | $7K |
| 2026-07-28 | 53 | $291.02 | $15K |
| 2026-07-06 | 100 | $287.77 | $29K |
| 2026-07-02 | 512 | $277.07 | $142K |
| 2026-06-22 | 156,016 | $279.27 | $43.6M |
| 2026-06-08 | 91 | $289.48 | $26K |
| 2026-05-29 | 2,556 | $284.33 | $727K |
| 2026-05-19 | 156 | $286.69 | $45K |
| 2026-04-20 | 20 | $278.64 | $6K |
| 2026-04-07 | 4 | $275.69 | $1K |
| 2026-04-06 | 4 | $270.02 | $1K |
| 2026-03-25 | 27 | $265.87 | $7K |
| 2026-02-25 | 5,894 | $281.00 | $1.7M |
| 2026-02-20 | 7,995 | $285.92 | $2.3M |
| 2026-02-13 | 11,346 | $287.61 | $3.3M |
| 2026-02-12 | 18 | $294.73 | $5K |
| 2026-01-21 | 17,560 | $271.24 | $4.8M |
| 2026-01-20 | 1,100 | $272.21 | $299K |
| 2025-12-30 | 122 | $276.01 | $34K |
| 2025-12-23 | 4,265 | $275.60 | $1.2M |
| 2025-12-22 | 61,120 | $271.89 | $16.6M |
| 2025-12-15 | 315 | $274.70 | $87K |
| 2025-12-12 | 348 | $272.26 | $95K |
| 2025-12-10 | 75 | $262.71 | $20K |
| 2025-11-25 | 31,639 | $271.47 | $8.6M |
| 2025-11-24 | 8,043 | $278.09 | $2.2M |
| 2025-11-20 | 20 | $271.99 | $5K |
| 2025-11-14 | 769 | $270.89 | $208K |
Insider trades
SEC Form 4, newest first. JSONInsiders at CI reported 3 open-market sells worth $6.3M in the last 90 days and no open-market buys. Latest filing: Neville Everett (See Remarks) on 2026-09-03.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Neville Everett | See Remarks | Sell | 617 | $284.05 | $175K | 5K |
| 2026-09-01 | Evanko Brian C | See Remarks | Grant | 3K | $0.00 | $0 | 41K |
| 2026-08-18 | Jones Nicole S | See Remarks | Sell | 3K | $279.61 | $749K | 26K |
| 2026-08-05 | Jones Nicole S | See Remarks | Exercise or conversion | 1K | $192.02 | $250K | 29K |
| 2026-08-04 | Jones Nicole S | See Remarks | Sell | 19K | $276.27 | $5.4M | 27K |
| 2026-08-04 | Jones Nicole S | See Remarks | Exercise or conversion | 14K | $192.02 | $2.7M | 47K |
| 2026-06-12 | Kates Jamie G | Chief Accounting Officer | Sell | 899 | $298.61 | $268K | 2K |
| 2026-06-12 | Kates Jamie G | Chief Accounting Officer | Exercise or conversion | 899 | $152.89 | $137K | 3K |
| 2026-06-01 | Koka Durga Prasad | EVP, Global CIO | Tax withholding | 729 | $275.53 | $201K | 7K |
| 2026-05-13 | Cordani David | Chairman & CEO | Exercise or conversion | 8K | $197.35 | $1.6M | 58K |
| 2026-05-13 | Cordani David | Chairman & CEO | Exercise or conversion | 15K | $149.13 | $2.3M | 50K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 2K | $298.53 | $666K | 34K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 15K | $298.24 | $4.6M | 37K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 2K | $296.84 | $599K | 52K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 35K | $295.98 | $10.3M | 54K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 38K | $294.98 | $11.4M | 89K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 2K | $293.92 | $630K | 127K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 8K | $292.88 | $2.3M | 129K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 12K | $291.95 | $3.6M | 137K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 14K | $291.01 | $4.0M | 149K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 41K | $290.00 | $11.9M | 163K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 14K | $288.85 | $4.0M | 204K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 14K | $287.96 | $4.1M | 218K |
| 2026-05-12 | Cordani David | Chairman & CEO | Sell | 4K | $286.83 | $1.1M | 232K |
| 2026-05-12 | Cordani David | Chairman & CEO | Exercise or conversion | 86K | $197.35 | $16.9M | 236K |
| 2026-05-12 | Cordani David | Chairman & CEO | Exercise or conversion | 104K | $149.13 | $15.4M | 151K |
| 2026-04-22 | FOSS ERIC J | Director | Grant | 782 | $0.00 | $0 | 37K |
| 2026-04-22 | McClellan Mark B. | Director | Grant | 782 | $0.00 | $0 | 7K |
| 2026-04-22 | Hathi Neesha | Director | Grant | 782 | $0.00 | $0 | 4K |
| 2026-04-22 | ZARCONE DONNA F | Director | Grant | 782 | $0.00 | $0 | 28K |
| 2026-04-22 | MAZZARELLA KATHLEEN M | Director | Grant | 782 | $0.00 | $0 | 7K |
| 2026-04-22 | Kurian George | Director | Grant | 782 | $0.00 | $0 | 5K |
| 2026-04-22 | Ross Kimberly A. | Director | Grant | 782 | $0.00 | $0 | 5K |
| 2026-04-22 | Hennigan Michael J | Director | Grant | 782 | $0.00 | $0 | 1K |
| 2026-04-22 | Ozuah Philip | Director | Grant | 782 | $0.00 | $0 | 3K |
| 2026-04-22 | WISEMAN ERIC C | Director | Grant | 782 | $0.00 | $0 | 24K |
| 2026-03-02 | Neville Everett | See Remarks | Sell | 2K | $288.91 | $497K | 6K |
| 2026-03-02 | Jones Nicole S | See Remarks | Sell | 2K | $288.91 | $667K | 33K |
| 2026-02-27 | Kates Jamie G | Chief Accounting Officer | Tax withholding | 61 | $287.55 | $18K | 2K |
| 2026-02-27 | Kates Jamie G | Chief Accounting Officer | Tax withholding | 71 | $287.55 | $20K | 2K |
| 2026-02-27 | Kates Jamie G | Chief Accounting Officer | Grant | 609 | $0.00 | $0 | 3K |
| 2026-02-27 | Kates Jamie G | Chief Accounting Officer | Grant | 205 | $0.00 | $0 | 2K |
| 2026-02-27 | Koka Durga Prasad | EVP, Global CIO | Tax withholding | 98 | $287.55 | $28K | 7K |
| 2026-02-27 | Koka Durga Prasad | EVP, Global CIO | Tax withholding | 122 | $287.55 | $35K | 7K |
| 2026-02-27 | Koka Durga Prasad | EVP, Global CIO | Grant | 3K | $0.00 | $0 | 8K |
| 2026-02-27 | Koka Durga Prasad | EVP, Global CIO | Grant | 499 | $0.00 | $0 | 5K |
| 2026-02-27 | Neville Everett | See Remarks | Tax withholding | 517 | $287.55 | $149K | 7K |
| 2026-02-27 | Neville Everett | See Remarks | Tax withholding | 883 | $287.55 | $254K | 8K |
| 2026-02-27 | Neville Everett | See Remarks | Grant | 3K | $0.00 | $0 | 9K |
| 2026-02-27 | Neville Everett | See Remarks | Grant | 3K | $0.00 | $0 | 6K |
| 2026-02-27 | Jones Nicole S | See Remarks | Tax withholding | 912 | $287.55 | $262K | 35K |
| 2026-02-27 | Jones Nicole S | See Remarks | Tax withholding | 2K | $287.55 | $525K | 36K |
| 2026-02-27 | Jones Nicole S | See Remarks | Grant | 5K | $0.00 | $0 | 38K |
| 2026-02-27 | Jones Nicole S | See Remarks | Grant | 4K | $0.00 | $0 | 32K |
| 2026-02-27 | Evanko Brian C | See Remarks | Tax withholding | 2K | $287.55 | $514K | 38K |
| 2026-02-27 | Evanko Brian C | See Remarks | Tax withholding | 3K | $287.55 | $857K | 40K |
| 2026-02-27 | Evanko Brian C | See Remarks | Grant | 10K | $0.00 | $0 | 43K |
| 2026-02-27 | Evanko Brian C | See Remarks | Grant | 6K | $0.00 | $0 | 33K |
| 2026-02-27 | DENNISON ANN M | EVP, CFO | Tax withholding | 409 | $287.55 | $118K | 8K |
| 2026-02-27 | DENNISON ANN M | EVP, CFO | Grant | 5K | $0.00 | $0 | 8K |
| 2026-02-27 | Cordani David | Chairman & CEO | Tax withholding | 4K | $287.55 | $1.3M | 47K |
| 2026-02-27 | Cordani David | Chairman & CEO | Tax withholding | 11K | $287.55 | $3.2M | 52K |
| 2026-02-27 | Cordani David | Chairman & CEO | Grant | 17K | $0.00 | $0 | 63K |
| 2026-02-27 | Cordani David | Chairman & CEO | Grant | 24K | $0.00 | $0 | 45K |
| 2025-11-03 | Cordani David | Chairman & CEO | Buy | 4K | $241.88 | $1000K | 158K |
| 2025-10-06 | Evanko Brian C | See Remarks | Exercise or conversion | 901 | $139.22 | $125K | 52K |
| 2025-10-03 | Evanko Brian C | See Remarks | Sell | 5K | $300.00 | $1.6M | 51K |
| 2025-10-03 | Evanko Brian C | See Remarks | Exercise or conversion | 5K | $139.22 | $747K | 57K |
| 2025-08-29 | BRAILER DAVID J | EVP & Chief Health Officer | Tax withholding | 290 | $300.66 | $87K | 18K |
| 2025-08-18 | Jones Nicole S | See Remarks | Exercise or conversion | 1K | $197.35 | $262K | 28K |
| 2025-08-18 | Jones Nicole S | See Remarks | Exercise or conversion | 1K | $183.44 | $247K | 27K |
| 2025-08-15 | Jones Nicole S | See Remarks | Sell | 29K | $300.00 | $8.6M | 26K |
| 2025-08-15 | Jones Nicole S | See Remarks | Exercise or conversion | 12K | $183.44 | $2.1M | 54K |
| 2025-08-15 | Jones Nicole S | See Remarks | Exercise or conversion | 13K | $197.35 | $2.6M | 43K |
| 2025-06-02 | Hennigan Michael J | Director | Grant | 568 | $0.00 | $0 | 568 |
| 2025-04-23 | FOSS ERIC J | Director | Grant | 638 | $0.00 | $0 | 36K |
| 2025-04-23 | Granger Elder | Director | Grant | 638 | $0.00 | $0 | 6K |
| 2025-04-23 | Hathi Neesha | Director | Grant | 638 | $0.00 | $0 | 3K |
| 2025-04-23 | MAZZARELLA KATHLEEN M | Director | Grant | 638 | $0.00 | $0 | 6K |
| 2025-04-23 | McClellan Mark B. | Director | Grant | 638 | $0.00 | $0 | 6K |
| 2025-04-23 | Ozuah Philip | Director | Grant | 638 | $0.00 | $0 | 2K |
| 2025-04-23 | Ross Kimberly A. | Director | Grant | 638 | $0.00 | $0 | 5K |
| 2025-04-23 | Kurian George | Director | Grant | 638 | $0.00 | $0 | 4K |
| 2025-04-23 | WISEMAN ERIC C | Director | Grant | 638 | $0.00 | $0 | 23K |
| 2025-04-23 | ZARCONE DONNA F | Director | Grant | 638 | $0.00 | $0 | 27K |
| 2025-03-14 | Granger Elder | Director | Sell | 2K | $310.35 | $737K | 5K |
| 2025-03-14 | Granger Elder | Director | Exercise or conversion | 2K | $151.48 | $360K | 8K |
| 2025-03-07 | Eder Noelle K | See Remarks | Sell | 10K | $320.00 | $3.2M | 13K |
| 2025-03-03 | Jones Nicole S | See Remarks | Sell | 5K | $308.12 | $1.5M | 29K |
| 2025-03-03 | Cordani David | Chairman & CEO | Sell | 27K | $308.12 | $8.2M | 128K |
| 2025-02-28 | Jones Nicole S | See Remarks | Tax withholding | 949 | $305.86 | $290K | 38K |
| 2025-02-28 | Jones Nicole S | See Remarks | Tax withholding | 4K | $305.86 | $1.3M | 34K |
| 2025-02-28 | Jones Nicole S | See Remarks | Grant | 3K | $0.00 | $0 | 39K |
| 2025-02-28 | Jones Nicole S | See Remarks | Grant | 9K | $0.00 | $0 | 36K |
| 2025-02-28 | Cordani David | Chairman & CEO | Grant | 49K | $0.00 | $0 | 171K |
| 2025-02-28 | Cordani David | Chairman & CEO | Tax withholding | 5K | $305.86 | $1.4M | 177K |
| 2025-02-28 | Cordani David | Chairman & CEO | Tax withholding | 23K | $305.86 | $7.0M | 154K |
| 2025-02-28 | Cordani David | Chairman & CEO | Grant | 11K | $0.00 | $0 | 182K |
| 2025-02-28 | Evanko Brian C | See Remarks | Tax withholding | 2K | $305.86 | $527K | 57K |
| 2025-02-28 | Evanko Brian C | See Remarks | Tax withholding | 6K | $305.86 | $1.7M | 51K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON9 Form 144 notices on file for CI worth $70.2M at the prices reported; 3 in the last 90 days worth $6.3M. Latest: Neville Everett filed on 2026-09-03 to sell 617 shares ($175K) from 2026-09-03.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-03 | Neville EverettOfficer | 617 | $175K | 0.000% | 2026-09-03 | Fidelity Brokerage Services LLC |
| 2026-08-18 | Jones Nicole SOfficer | 3K | $748K | 0.001% | 2026-08-18 | Fidelity Brokerage Services LLC |
| 2026-08-04 | Jones Nicole SOfficer | 19K | $5.4M | 0.007% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-06-12 | Kates Jamie GOfficer | 899 | $268K | 0.000% | 2026-06-12 | Fidelity Brokerage Services LLC |
| 2026-05-12 | Cordani DavidOfficer, Director | 202K | $59.1M | 0.076% | 2026-05-12 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Jones Nicole SOfficer | 2K | $667K | 0.001% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Neville EverettOfficer | 2K | $497K | 0.001% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-02-06 | Granger ElderFormer Director | 6K | $1.8M | 0.002% | 2026-02-06 | Fidelity Brokerage Services LLC |
| 2025-10-03 | Evanko Brian COfficer | 5K | $1.6M | 0.002% | 2025-10-03 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of CI in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (19,814,433 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 19.8M | 7.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 8 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-11-05 | 13G/Ano. 1 | FMR LLCparent holding company | 10.7M | 4.0% | 2025-09-30 |
| 2025-11-05 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 10.7M | 4.0% | 2025-09-30 |
13F holders
Tracked managers holding CI at their latest 13F. JSON9 of the 30 tracked managers held CI at their latest 13F, $1.33B in total at quarter-end prices. Two Sigma Investments is the largest at $499.8M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 1.8M | $499.8M | 0.36% | +1.2M |
| AQR Capital Management | 2026-06-30 | 1.4M | $396.0M | 0.14% | -1.2M |
| Millennium Management | 2026-06-30 | 456K | $125.6M | 0.05% | +330K |
| Renaissance Technologies | 2026-06-30 | 345K | $95.2M | 0.13% | +127K |
| Citadel Advisors | 2026-06-30 | 321K | $88.6M | 0.01% | -12K |
| D. E. Shaw & Co. | 2026-06-30 | 280K | $77.2M | 0.04% | +256K |
| Greenlight Capital (DME Capital) | 2026-06-30 | 88K | $24.4M | 0.62% | 0 |
| Bridgewater Associates | 2026-06-30 | 88K | $24.2M | 0.10% | -141K |
| Fisher Asset Management | 2026-06-30 | 4K | $1.2M | 0.00% | +3K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Cigna Group reported revenue of $71.67B, up 6.7% from the same quarter a year earlier, and net income of $1.66B (6.29 diluted EPS). In FY 2025 it generated $9.60B of operating cash flow and spent $3.62B on buybacks and $1.61B on dividends. As of 2026-06-30, cash was $6.30B against $2.79B of debt.
- Cash
- $6.30B
- Debt
- $2.79B
- Equity
- $42.62B
- Total assets
- $157.08B
- Shares outstanding
- 264,240,486
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $71.67B | $1.66B | 2.3% | 6.29 |
| Q1 FY 2026 | 2026-03-31 | $68.49B | $1.65B | 2.4% | 6.26 |
| Q4 FY 2025derived | 2025-12-31 | $72.47B | n/a | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | $69.75B | n/a | n/a | 6.98 |
| Q2 FY 2025 | 2025-06-30 | $67.18B | $1.53B | 2.3% | 5.71 |
| Q1 FY 2025 | 2025-03-31 | $65.50B | $1.32B | 2.0% | 4.85 |
| Q4 FY 2024derived | 2024-12-31 | $65.65B | n/a | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | $63.69B | n/a | n/a | 2.63 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $274.90B | $5.96B | $9.60B | n/a | $3.62B | $1.61B |
| FY 2024 | 2024-12-31 | $247.12B | $3.43B | $10.36B | n/a | $7.03B | $1.57B |
| FY 2023 | 2023-12-31 | $195.26B | $5.16B | $11.81B | n/a | $2.28B | $1.45B |
| FY 2022 | 2022-12-31 | $180.52B | n/a | $8.66B | n/a | $7.61B | $1.38B |
| FY 2021 | 2021-12-31 | $174.07B | n/a | $7.19B | n/a | $7.74B | $1.34B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
Cigna Group in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Cigna Group (CI), SEC CIK 1739940, listed on NYSE, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-25.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-03.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-03.JSON and CSV
- Company record
- EDGAR filing index for CIK 1739940Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as hospital & medical service plans
Other company pages
Datasets
Frequently Asked Questions
How much of CI is sold short?
What is CI's daily short volume?
Does CI have fails to deliver?
Are CI insiders buying or selling?
Have CI insiders filed to sell?
Who owns 5% or more of CI?
What did CI report last quarter?
Which tracked 13F managers own CI?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.